Universe · entity
Tri Locum Partners LP
Institutional manager (13F) · CIK 1826434
13F holdings · as of 2026-03-31 · top 17 · reported portfolio $713M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | JOHNSON & JOHNSON | $101M | 414,503 |
| 2 | INTUITIVE SURGICAL INC | $71M | 153,250 |
| 3 | THERMO FISHER SCIENTIFIC INC | $65M | 132,413 |
| 4 | ASCENDIS PHARMA A/S | $58M | 255,332 |
| 5 | VERTEX PHARMACEUTICALS INC | $58M | 129,314 |
| 6 | ELI LILLY & CO | $57M | 61,795 |
| 7 | MADRIGAL PHARMACEUTICALS INC | $54M | 103,288 |
| 8 | DEXCOM INC | $44M | 698,158 |
| 9 | UNITED THERAPEUTICS CORP DEL | $42M | 70,370 |
| 10 | NUVALENT INC | $32M | 308,506 |
| 11 | TEVA PHARMACEUTICAL INDS LTD | $31M | 1,021,008 |
| 12 | JAZZ PHARMACEUTICALS PLC | $30M | 158,663 |
| 13 | ARGENX SE | $23M | 31,635 |
| 14 | TARSUS PHARMACEUTICALS INC | $18M | 252,588 |
| 15 | DIANTHUS THERAPEUTICS INC | $12M | 145,543 |
| 16 | AXSOME THERAPEUTICS INC. | $10M | 62,116 |
| 17 | DEFINIUM THERAPEUTICS INC | $7M | 369,588 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.